Thiomolybdate analogues and uses thereof

Details Thiomolybdate analogues and uses thereof Thiomolybdate analogues and uses thereof

2007-03-13

2007-03-13

Davis, Brian (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heavy metal containing

C564S295000, C514S492000, C514S642000

Reexamination Certificate

active

10447585

ABSTRACT:
The current invention provides novel thiomolybdate derivatives, methods of making novel thiomolybdate derivatives, pharmaceutical compositions of novel thiomolybdate derivatives, methods of using novel thiomolybdate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-κB dysregulation and methods of using pharmaceutical compositions of thiomolybdate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-κB dysregulation.

REFERENCES:
patent: 2909541 (1959-10-01), Hugel
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4343746 (1982-08-01), Anglin et al.
patent: 4765539 (1988-08-01), Noakes et al.
patent: 5112598 (1992-05-01), Biesalski
patent: 5556611 (1996-09-01), Biesalski
patent: 5639725 (1997-06-01), O'Reilly et al.
patent: 5698155 (1997-12-01), Grosswald et al.
patent: 5950619 (1999-09-01), van der Linden et al.
patent: 5954047 (1999-09-01), Armer et al.
patent: 5970974 (1999-10-01), van der Linden et al.
patent: WO 99/20374 (1999-04-01), None
Alonso et al., Inorganica Chimica Acta (2001), 325, p. 193-197.
Bajou et al., “Absence of Host Plasminogen Activator Inhibitor 1 Prevents Cancer Invasion and Vascularization,”Nat. Med.(1998), 4:923-928.
Bamba et al., “Release Mechanisms in Gelforming Sustained Release Preparations,”Int. J. Pharm.(1979) 2:307.
Benjamin et al., “Selective Ablation of Immature Blood Vessels in Established Human Tumors Follows Vascular Endothelial Growth Factor Withdrawal,”J. Clin. Invest.(1999), 103: 159-165.
Blood et al., “Tumor Interactions With the Vasculature: Angiogenesis and Tumor Metastasis”Biochim. Biophys. Acta(1990), 1032:89-118.
Borgstrom et al., “Neutralizing Anti-Vascular Endothelial Growth Factor Antibody Completely Inhibits Angiogenesis and Growth of Human Prostate Carcinoma Micro Tumors in Vito,”Prostrate(1998), 35:1-10.
Brem et al., “Inhibition of Angiogenesis and Tumor Growth in the Brain,”Am. J. Pathol.(1990), 137(5): 1121-1142.
Brem et al., “Anti Copper Treatment Inhibits Pseudopodial Protrusion and the Invasive Spread of 9L Gliosarcoma Cells in the Rat Brain,”Neurosurgery(1990), 26:391-396.
Brown, “Metal Toxicity and Therapeutic Intervention,”Biochem. Soc. Trans(2002), 30:742-745.
Brown, “Copper and Prion Disease,”Brain Res. Bull.(2001), 55:165-173.
Carri et al., “Copper-Dependent Oxidative Stress, Alteration of Signal Transduction and Neurodegeneration in Amyothophic Lateral Sclerosis,”Funct. Neurol(2001), 16:181-188.
Chakravarty et al., “Serum Copper in Malignant Neoplasia with Special Reference to the Cervix Uteri,”J Cancer Res. Clin. Oncol.(1984), 108: 312-315.
Chambers et al., “Macrophage Colony-stimulating Factor Mediates Invasion of Ovarian Cancer Cells through Urokinase,”Canc. Res.(1995), 55:1578-1585.
Chen et al., “TNF-R1 Signaling: A Beautiful Pathway,”Science(2002), 296:1634-1635.
Crowley et al., “Prevention of Metastasis by Inhibition of the Urokinase Receptor,”Proc. Natl. Acad. Sci. USA(1993), 90:5021-5025.
During et al., “Controlled Release of Dopamine from a Polymeric Brain Implant; In Vivo Characterization,”Ann. Neurol.(1989) 25:351-356.
Folkman, “Anti-Angiogenesis: New Concept for Therapy of Solid Tumors,”Ann. Surg.(1972), 175: 409-416.
Folkman, “The Influence of Angiogenesis Research on Management of Patients with Breast Cancer,”Breast Cancer Res. Treat(1995), 36(2): 109-118.
Folkman, “Angiogenesis Inhibitors Generated by Tumors,”Mol. Med.(1995), 1(2): 120-122.
Gnjec et al., “Transition Metal Chelator Therapy—A potential Treatment For Alzheimer's Disease?”Front Biosci.(2002), 16-23.
Goodson, “Medical Applications of Controlled Release” (1984), 2: 115-138.
Gorelik et al., “Control of Lung Metastasis Progression in Mice: Role of Growth Kinetics of 3LL Lewis Lung Carcinoma and Host Immune Reactivity,”J. Nat'l. Canc. Inst.(1980), 65:1257-1264.
Gorelik, et al., “Host's Immune State and Kinetics of Local Tumor Growth Control—Progression of Postoperative Lung Metastasis,”Rec. Results Canc. Res.(1980), 75:20-28.
Gullino, “Considerations on the Mechanism of the Angiogenic Response,”Anticancer Res.(1986), 6:153-158.
Hanada, et al., “Regulation of Cytokine Signaling and Inflammation,”Cytokine Growth Factor Rev.(2002), 13: 413-421.
Hanahan et al., “Patterns and Emerging Mechanisms of the Angiogenic Switch During Tumorigenesis,”Cell(1996), 86(3): 353-364.
Hilgard et al., “Oral Anticoagulation in the Treatment of a Spontaneously Metastasising Murine Tumor (3LL),”Br. J. Cancer(1977), 35:78-86.
Howard et al., “Intracerebral drug delivery in rats with lesion-induced memory deficits,”J. Neurosurg.(1989) 71:105-112.
Isakov et al., “An Immune Response Against the Alloantigens of the 3LL Lewis Lung Carcinoma Prevents the Growth of Lung Metastases, but Not of Local Allografts,”Invasion Metas.(1982), 2:12-32.
Kleinman et al., “Basement Membrane Complexes with Biological Activity,”Biochemistry(1986), 25: 312-318.
Koch et al., “Interleukin-8 as a Macrophage-Derived Mediator of Angiogenesis,”Science(1992), 258:1798-1801.
Kowalik-Jankowska et al., “Possible Involvement of Copper (II) in Alzheimer Disease,”Environ Health Perspect.(2002), 5: 869-870.
Langer et al., “Chemical and Physical Structure of Polymers as Carriers for Controlled Release of Bioactive Agents: A Review,”J Macromol. Sci. Rev. Macromol Chem.(1983) 23:61-126.
Langer, “New Methods of Drug Delivery,”Science(1990) 249: 1527-1533.
Levy et al., Inhibition of Calcification of Bioprosthetic Heart Valves by Local Controlled-Release Diphosphonate,Science(1985) 228: 190-2.
Llanos et al., “The Molecular Basis of Copper Homeostasis and Copper-Related Disorders,”DNA Cell Biol.. (2002), 21: 259-270.
Loskutoff et al., “A Powerful Genetic Model to Study Hemostatic Gene Expression in Obesity/NIDDM,”Ann. N.Y. Acad. Sci.(2000), 902:272-282.
Malave et al., “Influence of Inoculation Site on Development of the Lewis Lung Carcinoma and Suppressor Cell Activity in Syngeneic Mice,”J. Nat'l. Canc. Inst.(1979), 62:83-88.
Mandinov, et al., “Copper Chelation Represses the Vascular Response To Injury”PNAS(2003), 100:6700-6705.
Maynard et al., “Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron,”J. Biol. Chem.(2002), 277(47):44670-44676.
Merajver et al., “Copper depletion as an anti-angiogenic strategy in HER2-neu transgenic mice,”Proceedings of Special AACR Conference on Angiogenesis and Cancer, Abstract #B-11, Jan. 22-24, (1998).
Millauer et al., “Dominant-Negative Inhibition of Flk-1 Suppresses the Growth of Many Tumor Types inVivo,” Cancer Res.(1996), 56:1615-1620.
Min et al., “Urokinase Receptor Antagonists Inhibit Angiogenesis and Primary Tumor Growth in Syngeneic Mice,”Cancer Res.(1996) 56: 2428-2433.
Miyake et al., “Transforming Growth Factor-β1 Stimulates Contraction of Human Glioblastoma Cell-Mediated Collagen Lattice through Enhanced α2 Integrin Expression,”J. Neuropathol. Exp. Neurol.(2000), 59:18-28.
Nguyen et al., “Quantitation of Angiogenesis and Antiangiogenesis in the Chick Embryo Chorioallantoic Membrane,”Microvascular Res.(1994), 47:31-40.
Odedra et al., “Low Molecular Weight Angiogenesis Factors,”Pharmac. Ther.(1991), 49:111-124.
Osawa et al., “Tumor Necrosis Factor Alpha-Induced Interleukin-8 Production via NF-κB and Phosphatidylinositol 3-K

Affiliated with

Also associated with

Rating

Thiomolybdate analogues and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thiomolybdate analogues and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thiomolybdate analogues and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3730946